Contact

All Stories

  1. Differential microvascular endothelial cell responses in the retina in diabetes compared to the heart and kidneys, a spatial transcriptomic analysis

    Article • PLOS One, December 2024, PLOS

    Dr Subrata Chakrabarti

  2. DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis

    Article • Cell Death and Differentiation, October 2024, Springer Science + Business Media

    Dr Subrata Chakrabarti

  3. CircRNA_012164/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathy

    Article • PLOS One, July 2024, PLOS

    Dr Subrata Chakrabarti

  4. Cardiac resident macrophages: Spatiotemporal distribution, development, physiological functions, and their translational potential on cardiac diseases

    Article • Acta Pharmaceutica Sinica B, January 2024, Elsevier

    Dr Subrata Chakrabarti

  5. Renewal of embryonic and neonatal-derived cardiac-resident macrophages in response to environmental cues abrogated their potential to promote cardiomyocyte proliferation via Jagged-1–Notch1

    Article • Acta Pharmaceutica Sinica B, January 2023, Elsevier

    Dr Subrata Chakrabarti

  6. Junctophilin-2 promotes cardiomyocyte survival by blocking MURF1-mediated Junctin ubiquitination and proteasome-dependentdegradation

    Article • October 2022, Cold Spring Harbor Laboratory Press

    Dr Subrata Chakrabarti

  7. Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1

    Article • PLOS One, October 2022, PLOS

    Dr Subrata Chakrabarti

  8. ANRIL regulates multiple molecules of pathogenetic significance in diabetic nephropathy

    Article • PLOS One, August 2022, PLOS

    Dr Subrata Chakrabarti

  9. Expressions of Serum lncRNAs in Diabetic Retinopathy – A Potential Diagnostic Tool

    Article • Frontiers in Endocrinology, April 2022, Frontiers

    Dr Subrata Chakrabarti

  10. IgG4-related disease as a rare cause of gastric outlet obstruction: a case report and literature review

    Article • BMC Gastroenterology, September 2021, Springer Science + Business Media

    Dr Subrata Chakrabarti

  11. The Long Non-Coding RNA HOTAIR Is a Critical Epigenetic Mediator of Angiogenesis in Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, March 2021, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  12. Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network

    Article • Journal of Clinical Medicine, July 2019, MDPI AG

    Dr Subrata Chakrabarti

  13. Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients

    Article • Clinical Ophthalmology, July 2019, Dove Medical Press

    Cindy Hutnik, Dr Subrata Chakrabarti

  14. Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture

    Article • Clinical Ophthalmology, July 2019, Dove Medical Press

    Dr Subrata Chakrabarti , Cindy Hutnik

  15. Nerve and Retinal Changes in Experimental Diabetes

    Article • May 2018, Taylor & Francis

    Dr Subrata Chakrabarti

  16. MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy

    Article • Scientific Reports, April 2018, Springer Science + Business Media

    Dr Subrata Chakrabarti

  17. ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications

    Article • AJP Endocrinology and Metabolism, March 2018, American Physiological Society

    Dr Subrata Chakrabarti

  18. Tuning the Optical Properties of Silicon Quantum Dots via Surface Functionalization with Conjugated Aromatic Fluorophores

    Article • Scientific Reports, February 2018, Springer Science + Business Media

    Dr Subrata Chakrabarti

  19. MALAT1: A regulator of inflammatory cytokines in diabetic complications

    Article • Endocrinology Diabetes & Metabolism, January 2018, Wiley

    Dr Subrata Chakrabarti

  20. Sex-specific analysis post-liver transplantation in hemochromatosis with aplastic anemia and hepatocellular carcinoma

    Article • Hepatology Communications, November 2017, Wiley

    Dr Subrata Chakrabarti

  21. H19 Regulates Glucose-Induced EndMT in Chronic Diabetic Complications

    Article • Canadian Journal of Diabetes, October 2017, Elsevier

    Dr Subrata Chakrabarti

  22. Role of Long Non-Coding RNA MALAT1 in the Pathogenesis of Diabetic Retinopathy

    Article • Canadian Journal of Diabetes, October 2017, Elsevier

    Dr Subrata Chakrabarti

  23. Decrease in Ins+Glut2LO β-cells with advancing age in mouse and human pancreas

    Article • Journal of Endocrinology, June 2017, Bioscientifica

    David Hill, Dr Subrata Chakrabarti

  24. Effect of ginseng therapy on diabetes and its chronic complications: lessons learned

    Article • Journal of Complementary and Integrative Medicine, May 2017, De Gruyter

    Dr Subrata Chakrabarti

  25. Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period

    Article • Eye, April 2017, Springer Science + Business Media

    Dr Subrata Chakrabarti

  26. Sitagliptin in Patients with Non-Alcoholic Steatohepatitis: A Randomized, Placebo-Controlled Trial

    Article • Gastroenterology, April 2017, Elsevier

    Dr Subrata Chakrabarti

  27. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes

    Article • Journal of Molecular and Cellular Cardiology, April 2017, Elsevier

    Dr Subrata Chakrabarti

  28. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes

    Article • PLOS One, March 2017, PLOS

    Dr Subrata Chakrabarti

  29. ANRIL: A Regulator of VEGF in Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, January 2017, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  30. Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial

    Article • World Journal of Gastroenterology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Subrata Chakrabarti

  31. Pathogenetic Mechanisms in Diabetic Retinopathy: From Molecules to Cells to Tissues

    Article • January 2017, Springer Science + Business Media

    Dr Subrata Chakrabarti

  32. We examined effects of acidic fibroblast growth factor on experimental diabetic nephropathy

    Article • January 2017, Karger Publishers

    Dr Subrata Chakrabarti

  33. miR-146a Regulates Glucose-Induced Upregulation of Inflammatory Cytokines in the Retina and Kidneys in DiabetesImage 2

    Article • Canadian Journal of Diabetes, October 2016, Elsevier

    Dr Subrata Chakrabarti

  34. Alterations of Long Noncoding RNAs (lncRNA) Cause Pathogenetic Changes in Diabetic RetinopathyImage 4

    Article • Canadian Journal of Diabetes, October 2016, Elsevier

    Dr Subrata Chakrabarti

  35. MicroRNA15a — A Molecule Modulating Multiple Pathologies in Diabetic Retinopathy

    Article • EBioMedicine, September 2016, Elsevier

    Dr Subrata Chakrabarti

  36. Adenoid cystic carcinoma presenting as an orbital apex mass with intracranial extension

    Article • Canadian Journal of Ophthalmology, April 2016, Elsevier

    Dr Subrata Chakrabarti

  37. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy

    Article • Diabetes, December 2015, American Diabetes Association

    Dr Subrata Chakrabarti

  38. Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases

    Article • Journal of Biological Chemistry, September 2015, Elsevier

    Dr Subrata Chakrabarti

  39. P63 Positive Mucoepidermoid Tumor of the Lacrimal Sac with Associated Papilloma

    Article • Orbit, June 2015, Taylor & Francis

    Dr Subrata Chakrabarti

  40. Collectivization of Vascular Smooth Muscle Cells via TGF-β–Cadherin-11–Dependent Adhesive Switching

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2015, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  41. Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relevance in Diabetic Retinopathy

    Article • PLOS One, April 2015, PLOS

    Dr Subrata Chakrabarti

  42. Unacylated Ghrelin: A Gut-Limb Connection: Figure 1

    Article • Diabetes, March 2015, American Diabetes Association

    Dr Subrata Chakrabarti

  43. Long non‐coding RNA MALAT 1 regulates hyperglycaemia induced inflammatory process in the endothelial cells

    Article • Journal of Cellular and Molecular Medicine, March 2015, Wiley

    Dr Subrata Chakrabarti

  44. SIRT 1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1

    Article • Journal of Cellular and Molecular Medicine, March 2015, Wiley

    Dr Subrata Chakrabarti

  45. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo

    Article • Journal of Molecular and Cellular Cardiology, February 2015, Elsevier

    Dr Subrata Chakrabarti

  46. Mechanisms of Endothelial to Mesenchymal Transition in the Retina in Diabetes

    Article • Investigative Ophthalmology & Visual Science, November 2014, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  47. Modulation of ERK5 Is a Novel Mechanism by Which Cdc42 Regulates Migration of Breast Cancer Cells

    Article • Journal of Cellular Biochemistry, November 2014, Wiley

    Dr Subrata Chakrabarti

  48. Erratum to “miRNA-1 regulates endothelin-1 in diabetes” [Life Sci. 98 (2014) 18–23]

    Article • Life Sciences, November 2014, Elsevier

    Dr Subrata Chakrabarti

  49. Reprint of: miRNA-1 regulates endothelin-1 in diabetes

    Article • Life Sciences, November 2014, Elsevier

    Dr Subrata Chakrabarti

  50. H19 Regulates Glucose-Induced Extracellular Matrix Protein Production in Diabetes

    Article • Canadian Journal of Diabetes, October 2014, Elsevier

    Dr Subrata Chakrabarti

  51. miR-200b Regulates Endothelial to Mesenchymal Transition in Diabetic Retinopathy

    Article • Canadian Journal of Diabetes, October 2014, Elsevier

    Dr Subrata Chakrabarti

  52. SIRT1 Causes Renal and Retinal Injury in Diabetes Through Endothelin 1 (ET-1) and Transforming Growth Factor β1 (TGF-β1)

    Article • Canadian Journal of Diabetes, October 2014, Elsevier

    Dr Subrata Chakrabarti

  53. Solitary fibrous tumour of the lacrimal sac presenting with recurrent dacryocystitis

    Article • Canadian Journal of Ophthalmology, October 2014, Elsevier

    Dr Subrata Chakrabarti

  54. Heparanase Shakes Hands With Lipoprotein Lipase: A Tale of Two Cells

    Article • Diabetes, July 2014, American Diabetes Association

    Dr Subrata Chakrabarti

  55. Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase

    Article • The Journal of Nutritional Biochemistry, April 2014, Elsevier

    Dr Subrata Chakrabarti

  56. miRNA-1 regulates endothelin-1 in diabetes

    Article • Life Sciences, March 2014, Elsevier

    Dr Subrata Chakrabarti

  57. miR-195 regulates SIRT1-mediated changes in diabetic retinopathy

    Article • Diabetologia, February 2014, Springer Science + Business Media

    Dr Subrata Chakrabarti

  58. MicroRNAs in diabetes - are they perpetrators in disguise or just epiphenomena?

    Article • Non-coding RNAs in Endocrinology, January 2014, De Gruyter

    Dr Subrata Chakrabarti

  59. Cardiac miR‐133a overexpression prevents early cardiac fibrosis in diabetes

    Article • Journal of Cellular and Molecular Medicine, January 2014, Wiley

    Dr Subrata Chakrabarti

  60. Cytokines and Diabetes Research

    Article • Journal of Diabetes Research, January 2014, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  61. The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage

    Article • PLOS One, December 2013, PLOS

    Dr Subrata Chakrabarti

  62. miRNA-1 Regulates endothelin-1 in diabetes

    Article • Life Sciences, December 2013, Elsevier

    Dr Subrata Chakrabarti

  63. Glucose-Induced Endothelial-to-Mesenchymal Transition in Retinal Endothelial Cells

    Article • Canadian Journal of Diabetes, October 2013, Elsevier

    Dr Subrata Chakrabarti

  64. MicroRNAs: The Underlying Mediators of Pathogenetic Processes in Vascular Complications of Diabetes

    Article • Canadian Journal of Diabetes, October 2013, Elsevier

    Dr Subrata Chakrabarti

  65. North American Ginseng (Panax quinquefolius) Prevents Hyperglycemia and Associated Pancreatic Abnormalities in Diabetes

    Article • Journal of Medicinal Food, July 2013, Mary Ann Liebert Inc

    Dr Subrata Chakrabarti

  66. Shedding light on a painful rash

    Article • Arab Journal of Gastroenterology, June 2013, Elsevier

    Dr Subrata Chakrabarti

  67. Oxidative-stress-induced epigenetic changes in chronic diabetic complications

    Article • Canadian Journal of Physiology and Pharmacology, March 2013, Canadian Science Publishing

    Dr Subrata Chakrabarti

  68. Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease

    Article • Alimentary Pharmacology & Therapeutics, February 2013, Wiley

    Dr Subrata Chakrabarti

  69. Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy

    Article • Heart Failure Reviews, February 2013, Springer Science + Business Media

    Dr Subrata Chakrabarti

  70. High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway

    Article • PLOS One, January 2013, PLOS

    Dr Subrata Chakrabarti

  71. ERK5 Regulates Glucose-Induced Increased Fibronectin Production in the Endothelial Cells and in the Retina in Diabetes

    Article • Investigative Ophthalmology & Visual Science, December 2012, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  72. Regulation of Vascular Endothelial Growth Factor Expression by Extra Domain B Segment of Fibronectin in Endothelial Cells

    Article • Investigative Ophthalmology & Visual Science, December 2012, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  73. Role of miRNA in Wound Healing in Diabetes

    Article • Canadian Journal of Diabetes, October 2012, Elsevier

    Dr Subrata Chakrabarti

  74. Glucose-induced SIRT Mediated Alterations in Microvascular Endothelial Cells

    Article • Canadian Journal of Diabetes, October 2012, Elsevier

    Dr Subrata Chakrabarti

  75. Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist

    Article • Life Sciences, October 2012, Elsevier

    Dr Subrata Chakrabarti

  76. Preventive effects of North American Ginseng (Panax quinquefolius) on Diabetic Retinopathy and Cardiomyopathy

    Article • Phytotherapy Research, May 2012, Wiley

    Dr Subrata Chakrabarti

  77. Tu1039 Is the Hyperferritinemia of Non-Alcoholic Fatty Liver Disease Related to Inflammation or Body Iron Stores?

    Article • Gastroenterology, May 2012, Elsevier

    Dr Subrata Chakrabarti

  78. Tu1040 Evaluation of Phlebotomy as a Therapy for Non-Alcoholic Fatty Liver Disease

    Article • Gastroenterology, May 2012, Elsevier

    Dr Subrata Chakrabarti

  79. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats

    Article • Diabetes/Metabolism Research and Reviews, May 2012, Wiley

    Dr Subrata Chakrabarti

  80. Preventive effects of North American ginseng (Panax quinquefolium) on diabetic nephropathy

    Article • Phytomedicine, April 2012, Elsevier

    Dr Subrata Chakrabarti

  81. miR-320 Regulates Glucose-Induced Gene Expression in Diabetes

    Article • ISRN Endocrinology, January 2012, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  82. The Impact of Population-Based Screening Studies on Hemochromatosis Screening Practices

    Article • Digestive Diseases and Sciences, December 2011, Springer Science + Business Media

    Dr Subrata Chakrabarti

  83. Glucose-Induced Cellular Signaling in Diabetic Retinopathy

    Article • December 2011, Springer Science + Business Media

    Dr Subrata Chakrabarti

  84. American ginseng (Panax quinquefolius) prevents glucose-induced oxidative stress and associated endothelial abnormalities

    Article • Phytomedicine, October 2011, Elsevier

    Dr Subrata Chakrabarti

  85. miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications

    Article • Diabetes, September 2011, American Diabetes Association

    Dr Subrata Chakrabarti

  86. Congenital choroidal melanoma in an infant

    Article • Canadian Journal of Ophthalmology, April 2011, Elsevier

    Dr Subrata Chakrabarti

  87. MicroRNA-200b Regulates Vascular Endothelial Growth Factor-Mediated Alterations in Diabetic Retinopathy

    Article • Diabetes, February 2011, American Diabetes Association

    Dr Subrata Chakrabarti

  88. A Context-Specific Role for Retinoblastoma Protein-Dependent Negative Growth Control in Suppressing Mammary Tumorigenesis

    Article • PLOS One, February 2011, PLOS

    Dr Subrata Chakrabarti

  89. Molecular Mechanisms in the Pathogenesis of Diabetic Cardiomyopathy

    Article • January 2011, Springer Science + Business Media

    Dr Subrata Chakrabarti

  90. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive

    Article • Genes & Development, June 2010, Cold Spring Harbor Laboratory Press

    Dr Subrata Chakrabarti

  91. CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice

    Article • Arthritis & Rheumatism, June 2010, Wiley

    Professor Joaquin (Quim) Madrenas, Dr Subrata Chakrabarti

  92. Glucose-induced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of diabetic ratsThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.

    Article • Canadian Journal of Physiology and Pharmacology, June 2010, Canadian Science Publishing

    Dr Subrata Chakrabarti

  93. Identification of Serum Biomarkers in End Stage Liver Disease

    Article • The Open Biomarkers Journal, January 2010, Bentham Science Publishers

    Dr Subrata Chakrabarti

  94. ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy

    Article • Journal of Ophthalmology, January 2010, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  95. miR133a regulates cardiomyocyte hypertrophy in diabetes

    Article • Diabetes/Metabolism Research and Reviews, January 2010, Wiley

    Dr Subrata Chakrabarti

  96. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells

    Article • AJP Endocrinology and Metabolism, January 2010, American Physiological Society

    Dr Subrata Chakrabarti

  97. The role of Akt1 in terminal stages of endochondral bone formation: Angiogenesis and ossification

    Article • Bone, December 2009, Elsevier

    Dr Subrata Chakrabarti

  98. Synchrotron X-ray microscopy and spectroscopy analysis of iron in hemochromatosis liver and intestines

    Article • Journal of Physics Conference Series, November 2009, Institute of Physics Publishing

    Dr Subrata Chakrabarti

  99. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB

    Article • Nutrition, September 2009, Elsevier

    Dr Subrata Chakrabarti

  100. Response to “Inhibition of p300 and nuclear factor-κB by curcumin and its role in diabetic nephropathy”

    Article • Nutrition, September 2009, Elsevier

    Dr Subrata Chakrabarti

  101. Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart disease

    Article • Diabetes/Metabolism Research and Reviews, July 2009, Wiley

    Dr Subrata Chakrabarti

  102. A Functional Connection between pRB and Transforming Growth Factor β in Growth Inhibition and Mammary Gland Development

    Article • Molecular and Cellular Biology, June 2009, ASM Journals

    Dr Subrata Chakrabarti

  103. Steatosis is a lot more than holes in hepatocytes

    Article • Saudi Journal of Gastroenterology, January 2009, Medknow

    Dr Subrata Chakrabarti

  104. Extracellular Matrix Proteins in Epiretinal Membranes and in Diabetic Retinopathy

    Article • Current Eye Research, January 2009, Taylor & Francis

    Dr Subrata Chakrabarti

  105. PARP mediates structural alterations in diabetic cardiomyopathy

    Article • Journal of Molecular and Cellular Cardiology, September 2008, Elsevier

    Dr Subrata Chakrabarti

  106. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes

    Article • Diabetes/Metabolism Research and Reviews, July 2008, Wiley

    Dr Subrata Chakrabarti

  107. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complicationsThis article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin.

    Article • Canadian Journal of Physiology and Pharmacology, June 2008, Canadian Science Publishing

    Dr Subrata Chakrabarti

  108. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level

    Article • AJP Endocrinology and Metabolism, April 2008, American Physiological Society

    Dr Subrata Chakrabarti

  109. P-18 Glucose induced oxidative stress may cause ERCC1-XPF upregulation via an epigenetic mechanism

    Article • Diabetes Research and Clinical Practice, February 2008, Elsevier

    Dr Subrata Chakrabarti

  110. CD5-1 Serum extra domain B containing fibronectin (EDB FN) — a biomarker for proliferative diabetic retinopathy

    Article • Diabetes Research and Clinical Practice, February 2008, Elsevier

    Dr Subrata Chakrabarti

  111. ERCC1 and XPF mediated upregulation of Fibronectin (FN) in Diabetes.

    Article • Canadian Journal of Diabetes, January 2008, Elsevier

    Dr Subrata Chakrabarti

  112. Is Serum Hepcidin Causative in Hemochromatosis? Novel Analysis from a Liver Transplant with Hemochromatosis

    Article • Canadian Journal of Gastroenterology, January 2008, Hindawi Publishing Corporation

    Vivian Charles McAlister, Dr Subrata Chakrabarti

  113. Hyperhexosemia-Induced Vasoactive Factors and Extracellular Matrix Protein Production in Kidneys are Mediated via NF-kB.

    Article • Canadian Journal of Diabetes, January 2008, Elsevier

    Dr Subrata Chakrabarti

  114. Akt activation and augmented fibronectin production in hyperhexosemia

    Article • AJP Endocrinology and Metabolism, October 2007, American Physiological Society

    Dr Subrata Chakrabarti

  115. Uveal metastasis from pulmonary large-cell neuroendocine carcinoma

    Article • Canadian Journal of Ophthalmology, October 2007, Elsevier

    Dr Subrata Chakrabarti

  116. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei

    Article • Cardiovascular Research, September 2007, European Society of Cardiology

    Sabzali Javadov, MD, PhD, FAHA, Dr Subrata Chakrabarti

  117. Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Sabzali Javadov, MD, PhD, FAHA, Dr Subrata Chakrabarti

  118. Clinical significance of the RT‐PCR positive sentinel node in melanoma

    Article • Journal of Surgical Oncology, January 2007, Wiley

    Dr Subrata Chakrabarti

  119. Diabetic Retinopathy: From Pathogenesis to Treatment

    Article • Experimental Diabetes Research, January 2007, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  120. Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy

    Article • Experimental Diabetes Research, January 2007, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  121. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy

    Article • Diabetes/Metabolism Research and Reviews, January 2007, Wiley

    Dr Subrata Chakrabarti

  122. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence

    Article • Liver Transplantation, January 2007, Wiley

    Dr Subrata Chakrabarti , Vivian Charles McAlister

  123. Diabetes-Induced Extracellular Matrix Protein Expression Is Mediated by Transcription Coactivator p300

    Article • Diabetes, November 2006, American Diabetes Association

    Dr Subrata Chakrabarti

  124. Endothelin-Mediated Oncofetal Fibronectin Expression in Chronic Allograft Nephropathy

    Article • Transplantation, August 2006, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  125. Vascular endothelial dysfunction in diabetic cardiomyopathy: Pathogenesis and potential treatment targets

    Article • Pharmacology & Therapeutics, August 2006, Elsevier

    Dr Subrata Chakrabarti

  126. Differential effects of curcumin on vasoactive factors in the diabetic rat heart

    Article • Nutrition & Metabolism, July 2006, Springer Science + Business Media

    Dr Subrata Chakrabarti

  127. Liver Diseases in the Hemochromatosis and Iron Overload Screening Study

    Article • Clinical Gastroenterology and Hepatology, July 2006, Elsevier

    Dr Subrata Chakrabarti

  128. Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications

    Article • Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery), June 2006, Bentham Science Publishers

    Dr Subrata Chakrabarti

  129. Towards Newer Molecular Targets for Chronic Diabetic Complications

    Article • Current Vascular Pharmacology, January 2006, Bentham Science Publishers

    Dr Subrata Chakrabarti

  130. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study

    Article • Clinical Genetics, December 2005, Wiley

    Dr Subrata Chakrabarti

  131. EDB fibronectin and angiogenesis – a novel mechanistic pathway

    Article • Angiogenesis, November 2005, Springer Science + Business Media

    Dr Subrata Chakrabarti

  132. Heme oxygenase modulates small intestine leukocyte adhesion following hindlimb ischemia/reperfusion by regulating the expression of intercellular adhesion molecule-1*

    Article • Critical Care Medicine, November 2005, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  133. Catastrophic microangiopathy induced by high-titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis

    Article • Haemophilia, November 2005, Wiley

    Vivian Charles McAlister, Dr Subrata Chakrabarti

  134. Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells

    Article • Diabetologia, September 2005, Springer Science + Business Media

    Dr Subrata Chakrabarti

  135. Leptin Induces Vascular Smooth Muscle Cell Hypertrophy through Angiotensin II- and Endothelin-1-Dependent Mechanisms and Mediates Stretch-Induced Hypertrophy

    Article • Journal of Pharmacology and Experimental Therapeutics, September 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Sabzali Javadov, MD, PhD, FAHA, Dr Subrata Chakrabarti

  136. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

    Article • Diabetologia, May 2005, Springer Science + Business Media

    Dr Subrata Chakrabarti

  137. Glucose-induced serum- and glucocorticoid-regulated kinase activation in oncofetal fibronectin expression

    Article • Biochemical and Biophysical Research Communications, April 2005, Elsevier

    Dr Subrata Chakrabarti

  138. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection

    Article • Transplant International, March 2005, Wiley

    Dr Subrata Chakrabarti

  139. Chemokine receptor CXCR4-β1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells

    Article • Biochemistry and Cell Biology, February 2005, Canadian Science Publishing

    Dr Tamas Oravecz, Dr Subrata Chakrabarti

  140. Endothelin-mediated remodeling in aortas of diabetic rats

    Article • Diabetes/Metabolism Research and Reviews, January 2005, Wiley

    Dr Subrata Chakrabarti

  141. Glucose-induced regulation of novel iron transporters in vascular endothelial cell dysfunction

    Article • Free Radical Research, January 2005, Taylor & Francis

    Dr Subrata Chakrabarti

  142. ED-B FIBRONECTIN IN NON–SMALL CELL LUNG CARCINOMA

    Article • Experimental Lung Research, January 2005, Taylor & Francis

    Dr Subrata Chakrabarti

  143. 2-Amino-phenoxazine-3-one Attenuates Glucose-Induced Augmentation of Embryonic Form of Myosin Heavy Chain, Endothelin-1 and Plasminogen Activator Inhibitor-1 in Human Umbilical Vein Endothelial Cells

    Article • Biological and Pharmaceutical Bulletin, January 2005, Pharmaceutical Society of Japan

    Dr Subrata Chakrabarti

  144. Pro-oxidant Role of Heme Oxygenase in Mediating Glucose-induced Endothelial Cell Damage

    Article • Free Radical Research, December 2004, Taylor & Francis

    Dr Subrata Chakrabarti

  145. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kB) in the retina

    Article • Acta Diabetologica, December 2004, Springer Science + Business Media

    Dr Subrata Chakrabarti

  146. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis

    Article • Laboratory Investigation, September 2004, Nature

    Dr Subrata Chakrabarti

  147. Vascular endothelial growth factor in diabetes induced early retinal abnormalities

    Article • Diabetes Research and Clinical Practice, September 2004, Elsevier

    Dr Subrata Chakrabarti

  148. Heme-oxygenase-mediated iron accumulation in the liver

    Article • Canadian Journal of Physiology and Pharmacology, July 2004, Canadian Science Publishing

    Dr Subrata Chakrabarti

  149. Potential Contributory Role of H-Ras, a Small G-Protein, in the Development of Retinopathy in Diabetic Rats

    Article • Diabetes, March 2004, American Diabetes Association

    Dr Subrata Chakrabarti

  150. Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas

    Article • Molecular and Cellular Endocrinology, January 2004, Elsevier

    Dr Subrata Chakrabarti

  151. Oncofetal Fibronectin in Diabetic Retinopathy

    Article • Investigative Ophthalmology & Visual Science, January 2004, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Subrata Chakrabarti

  152. C-peptide and Retinal Microangiopathy in Diabetes

    Article • Experimental Diabesity Research, January 2004, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  153. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina

    Article • Diabetes/Metabolism Research and Reviews, January 2004, Wiley

    Dr Subrata Chakrabarti

  154. Heme oxygenase in diabetes-induced oxidative stress in the heart

    Article • Journal of Molecular and Cellular Cardiology, December 2003, Elsevier

    Dr Subrata Chakrabarti

  155. Expression of ferroportin in hemochromatosis liver

    Article • Blood Cells Molecules and Diseases, September 2003, Elsevier

    Dr Subrata Chakrabarti

  156. Ex vivo and extracorporeal perfusion with hDAF pig kidneys*

    Article • Xenotransplantation, August 2003, Wiley

    Dr Subrata Chakrabarti

  157. Alteration in CD45RBhi/CD45RBlo T-cell ratio following CD45RB monoclonal-antibody therapy occurs by selective deletion of CD45RBhi effector cells

    Article • Transplantation, July 2003, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  158. Endothelins in chronic diabetic complications

    Article • Canadian Journal of Physiology and Pharmacology, June 2003, Canadian Science Publishing

    Dr Subrata Chakrabarti

  159. Differential activation of NF-κB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

    Article • AJP Endocrinology and Metabolism, June 2003, American Physiological Society

    Dr Subrata Chakrabarti

  160. Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line

    Article • Molecular and Cellular Endocrinology, March 2003, Elsevier

    Dr Subrata Chakrabarti

  161. Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation

    Article • Canadian Journal of Physiology and Pharmacology, February 2003, Canadian Science Publishing

    Dr Subrata Chakrabarti

  162. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1

    Article • AJP Cell Physiology, February 2003, American Physiological Society

    Dr Subrata Chakrabarti

  163. Growth Factors in Proliferative Diabetic Retinopathy

    Article • Experimental Diabesity Research, January 2003, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti , Prof. Dr. Otto W. Witte

  164. Endothelins and Cardiovascular Disease in Diabetes

    Article • January 2003, Springer Science + Business Media

    Dr Subrata Chakrabarti

  165. Diabetes-induced Activation of Nuclear Transcriptional Factor in the Retina, and its Inhibition by Antioxidants

    Article • Free Radical Research, January 2003, Taylor & Francis

    Dr Subrata Chakrabarti

  166. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of ??gal1

    Article • Transplantation, January 2003, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  167. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis

    Article • Hepatology, September 2002, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  168. A nomogram to predict C282Y hemochromatosis

    Article • Journal of Laboratory and Clinical Medicine, July 2002, Elsevier

    Dr Subrata Chakrabarti

  169. Natural History of C282Y Homozygotes for Hemochromatosis

    Article • Canadian Journal of Gastroenterology, January 2002, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  170. Alteration of Endothelins: A Common Pathogenetic Mechanism in Chronic Diabetic Complications

    Article • International Journal of Experimental Diabetes Research, January 2002, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  171. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium

    Article • Diabetes/Metabolism Research and Reviews, January 2002, Wiley

    Dr Subrata Chakrabarti

  172. Endothelin-1–Mediated Alteration of Metallothionein and Trace Metals in the Liver and Kidneys of Chronically Diabetic Rats

    Article • International Journal of Experimental Diabetes Research, January 2002, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  173. Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients

    Article • Clinical & Experimental Immunology, January 2002, Oxford University Press (OUP)

    Dr Subrata Chakrabarti

  174. Hyperhexosemia Induced Functional and Structural Changes in the Kidneys: Role of Endothelins

    Article • December 2001, Karger Publishers

    Dr Subrata Chakrabarti

  175. The α-gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts

    Article • Transplantation Proceedings, November 2001, Elsevier

    Dr Subrata Chakrabarti

  176. High-glucose-induced metallothionein expression in endothelial cells: an endothelin-mediated mechanism

    Article • AJP Cell Physiology, September 2001, American Physiological Society

    Dr Subrata Chakrabarti

  177. Empirical calculation of roll damping for ships and barges

    Article • Ocean Engineering, July 2001, Elsevier

    Dr Subrata Chakrabarti

  178. A new cause of Zollinger–Ellison syndrome: Non–Small cell lung cancer

    Article • Gastroenterology, April 2001, Elsevier

    Dr Subrata Chakrabarti

  179. Multiple Focal Nodular Hyperplasia and Steatohepatitis: Atypical Imaging Characteristics

    Article • Canadian Journal of Gastroenterology, January 2001, Hindawi Publishing Corporation

    Dr Subrata Chakrabarti

  180. Endothelins in the Microvasculature and Heart in Diabetes

    Article • January 2001, Springer Science + Business Media

    Dr Subrata Chakrabarti

  181. Therapeutic potential of endothelin receptor antagonists in diabetes

    Article • Expert Opinion on Investigational Drugs, December 2000, Informa Healthcare

    Dr Subrata Chakrabarti

  182. Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism

    Article • Urological Research, October 2000, Springer Science + Business Media

    Dr Subrata Chakrabarti

  183. Diabetes-induced Myocardial Structural Changes: Role of Endothelin-1 and its Receptors

    Article • Journal of Molecular and Cellular Cardiology, September 2000, Elsevier

    Dr Subrata Chakrabarti

  184. Interaction of Endothelin-1 with Vasoactive Factors in Mediating Glucose-Induced Increased Permeability in Endothelial Cells

    Article • Laboratory Investigation, August 2000, Nature

    Dr Subrata Chakrabarti

  185. Endothelin-1, endothelin-3 and their receptors (endothelin A and endothelin B ) in chronic renal transplant rejection in rats 1

    Article • Transplant International, June 2000, Frontiers

    Dr Subrata Chakrabarti

  186. Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors

    Article • Hepatology, May 2000, Wiley

    Dr Subrata Chakrabarti

  187. Endothelin-1, endothelin-3 and their receptors (endothelinAand endothelinB) in chronic renal transplant rejection in rats

    Article • Transplant International, May 2000, Wiley

    Dr Subrata Chakrabarti

  188. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats

    Article • Diabetes Research and Clinical Practice, May 2000, Elsevier

    Dr Subrata Chakrabarti

  189. UPREGULATION OF HEME OXYGENASE-1 ATTENUATES CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS.

    Article • Transplantation, April 2000, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  190. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats.

    Article • Diabetes, April 2000, American Diabetes Association

    Dr Subrata Chakrabarti

  191. Augmented expression of endothelin‐1, endothelin‐3 and the endothelin‐B receptor in breast carcinoma

    Article • Histopathology, February 2000, Wiley

    Dr Subrata Chakrabarti

  192. Diabetes-induced vascular dysfunction in the retina: role of endothelins

    Article • Diabetologia, October 1999, Springer Science + Business Media

    Dr Subrata Chakrabarti

  193. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors

    Article • Hepatology, September 1999, Wiley

    Dr Subrata Chakrabarti

  194. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.

    Article • Diabetes, September 1999, American Diabetes Association

    Dr Subrata Chakrabarti

  195. Leukocytes Utilize Both α4 andα5 Integrins for Intraislet Infiltration in Non-obese Diabetic Mice

    Article • Journal of Autoimmunity, May 1999, Elsevier

    Dr Bhagirath Singh, Dr Subrata Chakrabarti

  196. Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein

    Article • Toxicology, May 1999, Elsevier

    Dr Subrata Chakrabarti

  197. SPLENECTOMY AND LIVER TRANSPLANTATION: OUTCOME AND SEPSIS-RELATED MORTALITY

    Article • Transplantation, May 1999, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  198. Alternate Splicing Produces a Soluble Form of the Hereditary Hemochromatosis Protein Hfe

    Article • Blood Cells Molecules and Diseases, February 1999, Elsevier

    Dr Subrata Chakrabarti

  199. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion

    Article • AJP Heart and Circulatory Physiology, February 1999, American Physiological Society

    Dr Subrata Chakrabarti

  200. Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma

    Article • Histopathology, April 1998, Wiley

    Dr Subrata Chakrabarti

  201. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria

    Article • Gastroenterology, February 1998, Elsevier

    Dr Subrata Chakrabarti

  202. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes

    Article • Current Eye Research, January 1998, Taylor & Francis

    Dr Subrata Chakrabarti

  203. A Rapid Ischemia-induced Apoptosis in Isolated Rat Hearts and its Attenuation by the Sodium–Hydrogen Exchange Inhibitor HOE 642 (Cariporide)

    Article • Journal of Molecular and Cellular Cardiology, November 1997, Elsevier

    Dr Subrata Chakrabarti

  204. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

    Article • Journal of Clinical Investigation, November 1997, American Society for Clinical Investigation

    Dr Subrata Chakrabarti

  205. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats

    Article • Diabetes Research and Clinical Practice, August 1997, Elsevier

    Dr Subrata Chakrabarti

  206. Cocaine-Induced Ischemic Colitis with Small-Vessel Thrombosis of Colon and Gallbladder

    Article • Journal of Clinical Gastroenterology, January 1997, Wolters Kluwer Health

    Dr Subrata Chakrabarti

  207. Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood

    Article • Pediatric Nephrology, December 1994, Springer Science + Business Media

    Dr Subrata Chakrabarti

  208. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the

    Article • Diabetes Research and Clinical Practice, May 1993, Elsevier

    Dr Subrata Chakrabarti

  209. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat

    Article • Diabetologia, July 1992, Springer Science + Business Media

    Dr Subrata Chakrabarti

  210. The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy

    Article • Diabetologia, June 1992, Springer Science + Business Media

    Dr Subrata Chakrabarti

  211. The effect of myo-inositol treatment on basement membrane thickening in the retina

    Article • Diabetes Research and Clinical Practice, April 1992, Elsevier

    Dr Subrata Chakrabarti

  212. Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-rat

    Article • Diabetologia, April 1992, Springer Science + Business Media

    Dr Subrata Chakrabarti

  213. Effect of Insulin and Statil on Aldose Reductase Expression in Diabetic Rats

    Article • Diabetes, November 1991, American Diabetes Association

    Dr Subrata Chakrabarti

  214. Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat

    Article • Diabetologia, May 1991, Springer Science + Business Media

    Dr Subrata Chakrabarti

  215. Optic Neuropathy in the Diabetic BB-Rat

    Article • January 1991, Springer Science + Business Media

    Dr Subrata Chakrabarti

  216. Nerve growth factor (NGF), proNGF and NGF receptor-like immunoreactivity in BB rat retina

    Article • Brain Research, July 1990, Elsevier

    Dr Subrata Chakrabarti

  217. Insulin Regulation of IGF-I Expression in Rat Aorta

    Article • Diabetes, June 1990, American Diabetes Association

    Dr Subrata Chakrabarti

  218. Diabetic Autonomic Neuropathy in BB Rats and Effect of ARI Treatment on Heart-Rate Variability and Vagus Nerve Structure

    Article • Diabetes, May 1990, American Diabetes Association

    Dr Subrata Chakrabarti

  219. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

    Article • Journal of Clinical Investigation, May 1990, American Society for Clinical Investigation

    Dr Subrata Chakrabarti

  220. Localization of the Sites of Synthesis and Action of Insulin-Like Growth Factor-I in the Rat Uterus

    Article • Molecular Endocrinology, February 1990, Endocrine Society

    Dr Subrata Chakrabarti

  221. Augmented polyol pathway activity and retinal pigment epithelial permeability in the diabetic BB rat

    Article • Diabetes Research and Clinical Practice, January 1990, Elsevier

    Dr Subrata Chakrabarti

  222. The presence of anionic sites in basement membranes of cerebral capillaries

    Article • Microvascular Research, January 1990, Elsevier

    Dr Subrata Chakrabarti

  223. Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-rat

    Article • Diabetologia, November 1989, Springer Science + Business Media

    Dr Subrata Chakrabarti

  224. Effect of Aldose Reductase Inhibition and Insulin Treatment on Retinal Capillary Basement Membrane Thickening in BB Rats

    Article • Diabetes, September 1989, American Diabetes Association

    Dr Subrata Chakrabarti

  225. Increased Renal Aldose Reductase Activity, Immunoreactivity, and mRNA in Streptozocin-Induced Diabetic Rats

    Article • Diabetes, August 1989, American Diabetes Association

    Dr Subrata Chakrabarti

  226. Bone Mineral Metabolism in Experimental Diabetes Mellitus: Osteocalcin as a Measure of Bone Remodeling

    Article • Endocrinology, July 1988, Endocrine Society

    Dr Subrata Chakrabarti

  227. Pancreatic islet allograft prevents basement membrane thickening in the diabetic rat retina

    Article • Diabetologia, March 1988, Springer Science + Business Media

    Dr Subrata Chakrabarti

  228. Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat

    Article • Diabetologia, December 1987, Springer Science + Business Media

    Dr Subrata Chakrabarti

  229. Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve

    Article • Diabetologia, April 1987, Springer Science + Business Media

    Dr Subrata Chakrabarti

  230. A rapid reproducible method for determination of basement membrane thickness in biological structures

    Article • Computers in Biology and Medicine, January 1987, Elsevier

    Dr Subrata Chakrabarti

  231. Prevention of diabetic retinal capillary pericyte degeneration and loss by pancreatic islet allograft

    Article • Current Eye Research, January 1987, Taylor & Francis

    Dr Subrata Chakrabarti

  232. The BB-rat-an authentic model of human diabetic retinopathy

    Article • Current Eye Research, January 1985, Taylor & Francis

    Dr Subrata Chakrabarti